Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years
Zachary Oaks, Thomas Winans, Nick Huang, et al.
Current Rheumatology Reports (2016) Vol. 18, Iss. 12
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Vaishali R. Moulton, Abel Suárez‐Fueyo, Esra Meidan, et al.
Trends in Molecular Medicine (2017) Vol. 23, Iss. 7, pp. 615-635
Open Access | Times Cited: 408
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
Zhi‐Wei Lai, Ryan L. Kelly, Thomas Winans, et al.
The Lancet (2018) Vol. 391, Iss. 10126, pp. 1186-1196
Open Access | Times Cited: 353
A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate
Simone Caielli, Diogo F. T. Veiga, Preetha Balasubramanian, et al.
Nature Medicine (2018) Vol. 25, Iss. 1, pp. 75-81
Open Access | Times Cited: 233
Immunometabolism in systemic lupus erythematosus
Laurence Morel
Nature Reviews Rheumatology (2017) Vol. 13, Iss. 5, pp. 280-290
Closed Access | Times Cited: 192
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
Takayuki Katsuyama, George C. Tsokos, Vaishali R. Moulton
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 188
Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells
Shan Hu, Yingchun Xu, Liwei Meng, et al.
Experimental and Therapeutic Medicine (2018)
Open Access | Times Cited: 166
Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE
Simone Caielli, Jacob Cardenas, Adriana A. de Jesus, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4464-4479.e19
Open Access | Times Cited: 155
Cell type-specific regulation of the pentose phoshate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidites, carcinogenesis, and aging
Katalin Bánki, András Perl
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103781-103781
Closed Access | Times Cited: 2
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
Rob J.W. Arts, Leo A. B. Joosten, Mihai G. Netea
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 152
T cells and autoimmune kidney disease
Abel Suárez‐Fueyo, Sean J. Bradley, David Klatzmann, et al.
Nature Reviews Nephrology (2017) Vol. 13, Iss. 6, pp. 329-343
Closed Access | Times Cited: 120
Review: Metabolic Control of Immune System Activation in Rheumatic Diseases
András Perl
Arthritis & Rheumatology (2017) Vol. 69, Iss. 12, pp. 2259-2270
Open Access | Times Cited: 102
Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis
Yuanyuan Qi, Shufeng Zhou, Fajuan Cheng, et al.
Annals of the Rheumatic Diseases (2018) Vol. 77, Iss. 12, pp. 1799-1809
Open Access | Times Cited: 96
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story
Marco Quaglia, Guido Merlotti, Marco De Andrea, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 277-277
Open Access | Times Cited: 91
Oxidative Stress Contributes to Inflammatory and Cellular Damage in Systemic Lupus Erythematosus: Cellular Markers and Molecular Mechanism
Yan Zhu, Qin Chen, Yumin Xia
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 453-465
Open Access | Times Cited: 31
Immmunometabolism of systemic lupus erythematosus
Marlene Marte Furment, András Perl
Clinical Immunology (2024) Vol. 261, pp. 109939-109939
Closed Access | Times Cited: 9
Metabolic abnormalities and oxidative stress in lupus
Yaíma L. Lightfoot, Luz P. Blanco, Mariana J. Kaplan
Current Opinion in Rheumatology (2017) Vol. 29, Iss. 5, pp. 442-449
Open Access | Times Cited: 76
Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity
Takayuki Katsuyama, Hao Li, Denis Comte, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 12, pp. 5411-5423
Open Access | Times Cited: 76
Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Liyan Lin, Ruyu Ren, Qiao Xiong, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103583-103583
Open Access | Times Cited: 6
Control of B lymphocyte development and functions by the mTOR signaling pathways
Terri Iwata, Julita A. Ramírez-Komo, Heon Park, et al.
Cytokine & Growth Factor Reviews (2017) Vol. 35, pp. 47-62
Open Access | Times Cited: 54
Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway
Jingjing He, Jun Ma, Bingrui Ren, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 50, Iss. 2, pp. 314-320
Open Access | Times Cited: 48
Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients
Goh Murayama, Asako Chiba, Taiga Kuga, et al.
Lara D. Veeken (2020) Vol. 59, Iss. 10, pp. 2992-3002
Closed Access | Times Cited: 48
Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sjögren’s syndrome
María‐José Barrera, Sergio Aguilera, Isabel Castro, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 4, pp. 1951-1962
Closed Access | Times Cited: 46
Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis
Tiffany Caza, Chathura Wijewardena, Laith Al‐Rabadi, et al.
Translational research (2022) Vol. 245, pp. 55-81
Open Access | Times Cited: 23
Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives
Arash Soltani, Amirhossein Bahreyni, Nadia Boroumand, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 6, pp. 4783-4790
Closed Access | Times Cited: 42
Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
Per Eriksson, Philip Wallin, Christopher Sjöwall
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top